Fluorescein-tear breakup time as an assessment of efficacy of tear replacement therapy in dry eye patients: A systematic review and meta-analysis

Ocular Surface

Volumn 12, Issue 2, 2014, Pages 100-111

  Doughty, Michael J ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

Author keywords

Artificial tears; Dry eye; Fluorescein tear breakup time (fTBUT); Meta analysis; Systematic review

Indexed keywords

ARTIFICIAL TEAR; FLUORESCEIN;

AQUEOUS SOLUTION; CLINICAL ASSESSMENT; DRY EYE; FLUORESCEIN TEAR BREAKUP TIME; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PEER REVIEW; REVIEW; SUBSTITUTION THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; VISUAL SYSTEM EXAMINATION; VISUAL SYSTEM PARAMETERS; DIAGNOSTIC USE; DRY EYE SYNDROMES; LACRIMAL FLUID;

DRY EYE SYNDROMES; FLUORESCEIN; HUMANS; LUBRICANT EYE DROPS; TEARS;

EID: 84901497867     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2013.11.002     Document Type: Review

References (59)

1. (No authors listed). The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5: 75-92
2. Pflugfleder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: A twenty-five-year review. Cornea 2000;19: 644-9
3. (No authors listed). The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5: 93-107
4. Volker-Dieben HJ, Kok-Van Alphen CC, Hollander J, et al. The palliative treatment of dry eye. Doc Ophthalmol 1987;67: 221-7
5. Foulks GN. Challenges and pitfalls in clinical trials of treatment of dry eye. Ocul Surf 2003;1: 20-30
6. Dogru M, Tsubota K. Pharmacotherapy of dry eye. Expert Opin Pharmacother 2011;12: 325-34
7. Alves M, Fonseca EC, Alves MF, et al. Dry eye disease treatment: A systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf 2013;11: 181-92
8. Dilly PN. Contribution of the epithelium to the stability of the tear film. Trans Ophthalmol Soc UK 1985;104: 381-9
9. Petricek I, Berta A, Higazy MT, et al. Hydroxypropyl-guar gellable lubricant eye drops for dry eye treatment. Expert Opinion Pharmacother 2008;9: 1431-6
10. Sullivan DA, Hammitt KM, Schaumberg DA, et al. Report of the TFOS /ARVO symposium on global treatments for dry eye disease: An unmet need. Ocul Surf 2012;10: 108-16
11. Doughty MJ. A morphometric analysis of the surface cells of rabbit corneal epithelium by scanning electron microscopy. Am J Anat 1990;189: 316-28
12. Doughty MJ. Assessment of goblet cell orifice distribution across the rabbit bulbar conjunctiva based on numerical density and nearest neighbours analysis. Curr Eye Res 2013;38: 237-51
13. Doughty MJ. Re-wetting, comfort, lubricant and moisturising solutions for the contact lens wearer. Contact Lens Anterior Eye 1999;22: 116-26
14. Doughty MJ. Comparative anatomy and physiology of the cornea and conjunctiva. In: Martin HR, Corrales RM, eds. Ocular Surface. Boca Raton FL, CRC Press, 2012. p. 32-78
15. Doughty MJ. Impact of brief exposure to balanced salts solution or cetylpyridinium chloride on the surface appearance of the rabbit corneal epithelium e a scanning electron microscopy study. Curr Eye Res 2003;26: 335-46
16. Cho P, Leung L, Lam A, Choi A. Tear break-up time: clinical procedures and their effects. Ophthalmic Physiol Opt 1998;18: 319-24
17. Korb DR. Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 2000;19: 483-6
18. Nichols JJ, Nichols KK, Puent B, SaracinoM, et al. Evaluation of tear film interference patterns and measures of tear break up time. Optom Vis Sci 2002;79: 363-9
19. Nichols KK, Nichols JJ, Mitchell GL. The relation between tear film tests in patients with dry eye disease. Ophthalmic Physiol Opt 2003;23: 553-60
20. Doughty MJ. pH-dependent spectral properties of sodium fluorescein ophthalmic solutions revisited. Ophthalmic Physiol Opt 2010;30: 167-74
21. Doughty MJ, Jalota V, Bennett E, et al. Use of a high molecular weight fluorescein (fluorexon) ophthalmic strip in assessment of tear film break up time (TBUT) in contact lens wearers and non contact lens wearers. Ophthalmic Physiol Opt 2005;25: 119-27
22. Tsubota K, Asbell P, Dogru M, et al. Designs and conduct of clinical trials. Ocul Surf 2005;5: 153-62
23. Llamas-Moreno JF, Baiza-Durán LM, Saucedo-Rodríguez LR, Alaníz-De la O JF. Efficacy and safety of chondroitin sulfate /xanthan gum versus polyethylene glycol /propylene glycol /hydroxypropyl guar in patients with dry eye. Clin Ophthalmol 2013;7: 995-9
24. Moen BE, Norbäck D, Weislander G, et al. Can air pollution affect tear stability? BMC Public Health 2011;11: 235
25. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-88
26. Centre for Reviews and Dissemination. Systematic reviews. UK, University of York, 2009
27. Aragona P, Di Stefano G, Ferreri F, et al. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients. Br J Ophthalmol 2002;86: 879-84
28. Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLab osmolarity system in the assessment of dry eye treatment effectiveness. Cont Lens Anterior Eye 2010;33: 61-7
29. Bron AJ, Daubas P, Siou-Mermet R, Trinquand C. Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. Eye 1998;12: 839-47
30. Chiambaretta F, Pouliquen P, Menerath J-M, et al. [Efficacy and safety of a fluid carbomer gel versus a conventional carbomer gel in dry eye treatment]. J Fr Ophtalmol 2004;27: 130-5. French
31. Chung YW, Oh TH, Chung SK. The effect of topical cyclosporine 0.05% on dry eye after cataract surgery. Korean J Ophthalmol 2013;27: 167-71
32. Çömez AT, Tufan HA, Kocabbiyik O, Gencer B. Effects of lubricating agents with different osmolarity and other tear function tests in patients with dry eye. Curr Eye Res 2013;38: 1095-103
33. Gifford P, Evans BJW, Morris J. A clinical evaluation of Systane. Cont Lens Anterior Eye 2006;29: 31-40
34. Ibrahim OM, Dogru M, Kojima T, et al. OCT assessment of tear meniscus after punctal occlusion in dry eye disease. Optom Vis Sci 2012;89:E770-6
35. Iester M, Orsoni GJ, Gamba G, et al. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca. Eye 2000;14: 892-8
36. Johnson ME, Murphy PJ, Boulton M. Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment. Optom Vis Sci 2008;85: 750-7
37. Kamiya K, Nakanishi M, Ishii R, et al. Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome: a prospective, randomized, multicenter study. Eye 2012;26: 1363-8
38. Kim EC, Choi J-S, Joo C-K. A comparison of vitamin A and cyclosporine A 0.05% eyedrops for treatment of dry eye syndrome. Am J Ophthalmol 2009;147: 206-13
39. Kim T-H, Kang JW, Kim KH, et al. Acupuncture for the treatment of dry eye: A multicenter randomised controlled trial with active comparison intervention (artificial tears). PloS ONE 2012;7: 1-9
40. Kinoshita S, Awamura S, Oshiden K, et al. Rebamipide (OPC-12759) in the treatment of dry eye: A randomized, double-masked, multicenter, placebo-controlled phase II study. Ophthalmology 2012;119: 2471-8
41. Lee JH, Ahn HS, Kim EK, Kim TI. Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease. Cornea 2011;30: 175-9
42. Marquardt R. [Treatment of dry eye with a new gel in eyedrop form]. Klin Monatsbl Augenheilkd 1986;189: 51-4. German
43. Matsumoto Y, Ohashi Y, Watanabe H, Tsubota K. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: A Japanese phase 2 clinical trial. Ophthalmology 2012;119: 1954-60
44. Mayer H, Feuerhake C, Joost P, Sander U. [Clinical study of the effectiveness of a new preservative-free polyvidon preparation in therapy of dryeye disorders]. Klin Monatsbl Augenheilkd 1994;205: 138-42. German
45. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. Arch Ophthalmol 1988;106: 484-7
46. Rolando M, Valente C. Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study. BMC Ophthalmol 2007;7: 5
47. Sanchez MA, Torralbo-Jiminez P, Giron N, et al. Comparative analysis of carmellose 0.5% versus hyaluonate 0.15% in dry eye: A flow cytometric study. Cornea 2010;29: 167-71
48. Tauber J. Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome. Curr Med Res Opin 2007;23: 2629-38
49. Toda I, Shinozaki N, Tsubota K. Hydroxypropylmethylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15: 120-8
50. Vadillo Gonzalo MM, Abad JM, Verges Roger C, Salorio DP. [Therapeutic effects of Tear Guard in dry eye syndrome.]. Arch Soc Esp Oftalmol 1985;48: 299-302. Spanish
51. Versura P, Profazio V, Campos EC. One month use of Systane-improves ocular surface parameters in subjects with moderate symptoms of ocular dryness. Clin Ophthalmol 2008;2: 629-35
52. Versura P, Profazio V, Giannaccare G, et al. Discomfort symptoms reduction and ocular surface parameters recovery with Artelac Rebalance treatment in mild-moderate dry eye. Eur J Ophthalmol 2013;23: 488-95
53. Villani E, Laganovska G, Viola F, et al. A multicenter, double-blind, parallel group, placebo-controlled clinical study of examine the safety and efficacy of T-Clair SHHP700-3 in the management of mild-tomoderate dry eye in adults. Cornea 2011;30: 265-8
54. Waduthantri S, Yong SS, Tan CH, et al. Lubricant with gelling agents in treating dry eye in adult Chinese patients. Optom Vis Sci 2012;89: 1647-53
55. Wang I-J, Lin I-C, Hou Y-C, Hu F-R. A comparison of the effect of carbomer-, cellulose- and mineral oil-based artificial tear formulations. Eur J Ophthalmol 2007;17: 151-9
56. Wang T-J, Wang I-J, Ho J-D, et al. Comparison of the clinical effects of Carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: A 4-week, prospective, open-label, randomized, parallel-group, noninferiority study. Clin Ther 2010;32: 44-52
57. Wei D, Li YH, Zhou WY. [Observation on therapeutic effect of runmushu oral liquid in treating xerophthalmia in postmenopausal women]. Zhongguo Zhong Xi Yie He Za Zhi 2009;29: 646-9. Chinese
58. Doughty MJ, Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants e a systematic review. Ophthalmic Physiol Opt 2009;29: 573-83
59. Doughty MJ. Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease e a review. Cont Lens Anterior Eye 2013;36: 272-80